Klotho Neurosciences, Inc. (NASDAQ:KLTO – Get Free Report)’s stock price traded up 6% on Tuesday . The stock traded as high as $0.49 and last traded at $0.47. 51,172 shares were traded during trading, a decline of 96% from the average session volume of 1,217,764 shares. The stock had previously closed at $0.44.
Klotho Neurosciences Stock Up 2.0 %
The business’s fifty day moving average is $0.45.
Klotho Neurosciences Company Profile
Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.
Featured Stories
- Five stocks we like better than Klotho Neurosciences
- What is the Euro STOXX 50 Index?
- Micron Stock Under $100: Seize the AI-Driven Upside
- Earnings Per Share Calculator: How to Calculate EPS
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Klotho Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Klotho Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
